Aayush Wellness is currently trading at its upper circuit limit of Rs 32.23, up by 1.53 points or 4.98% from its previous closing of Rs 30.70 on the BSE.
The scrip opened at Rs 32.23 and has touched a high and low of Rs 32.23 and Rs 32.23 respectively. So far 118723 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs 267.30 on 18-Jul-2025 and a 52 week low of Rs 30.70 on 08-Dec-2025.
Last one week high and low of the scrip stood at Rs 32.23 and Rs 30.70 respectively. The current market cap of the company is Rs. 156.87 crore.
The Non-Institutions held 100.00% stake in the company.
Aayush Wellness has expanded its wellness portfolio with the launch of Immunity Booster Tablets, tapping into India’s rapidly growing $18 billion nutraceutical market. This strategic launch comes at a time when sedentary lifestyles, poor dietary choices, chronic stress, and seasonal changes have significantly weakened the immune resilience of millions. Designed to address this urgent need, the tablets offer a daily solution for strengthening the body's natural defense system in today’s fast-paced and health vulnerable environment.
In India, almost 38% of the population consumes an Unhealthy Diet, driven by urban lifestyles, lack of nutrition awareness, and economic constraints that make processed and high-calorie foods more accessible than minerals and nutrient-rich meals. Formulated with a potent blend of traditional and science-backed ingredients, Aayush Wellness’ Immunity Booster Tablets are designed to fortify the body’s natural defense system and promote daily resilience.
Aayush Wellness is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1682.90 |
| Dr. Reddys Lab | 1223.90 |
| Cipla | 1231.45 |
| Zydus Lifesciences | 937.40 |
| Lupin | 2309.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: